{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:52:06Z","timestamp":1781949126859,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Involv Engagem"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patient involvement within academic and for-profit medicines and medical technology research and development is happening across organisations and functions. Frameworks exist to conceptualise involvement activities along a spectrum based on patient contributions and their share of voice and decision-making. Examples range from Informing and Education of patients through to Co-design and Co-Production e.g., in research and development. Varying levels of patient expertise profiles also exist based on a spectrum of experience and expertise \u2013 from Patient by Experience through to Patient Key Opinion Leader (KOL) \u2013 though researchers often lack clarity on the most relevant skills and knowledge of patient partners suited to the task at hand. Here, we propose a conceptual matrix model combining these two concepts into a simple, pragmatic framework intended for patient involvement professionals in research and development, but with broader relevance for other contexts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>As authors with a mix of academic, for-profit industry, and patient advocacy backgrounds, we utilised intellectual exchange and consensus formation in three workshops to develop the model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We have developed a conceptual matrix model and applied illustrative case study examples from among our collective experiences and network to demonstrate the model in action. Trends in sample sizes, patient diversity, project longevity, and share of influence exist along the matrix axes. For example, greater numbers and diversity of patients are typically seen at the lower levels of involvement, where there is greater capacity for breadth of involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our aim for this model is to support and encourage patient involvement professionals to better determine appropriate levels of involvement and patient expertise needed for their projects and activities, enabling them to facilitate more appropriate, fair, effective, and sustainable patient involvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40900-026-00926-0","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:28:19Z","timestamp":1781947699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A conceptual matrix model of patient involvement and patient expertise in medicines and medical technology research and development"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-4291","authenticated-orcid":false,"given":"Adeline","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trishna","family":"Bharadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Yeoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"6","key":"926_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jval.2020.01.019","volume":"23","author":"RL Harrington","year":"2020","unstructured":"Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, et al. Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group. Value Health. 2020;23(6):677\u201388.","journal-title":"Value Health"},{"issue":"9","key":"926_CR2","doi-asserted-by":"publisher","first-page":"103702","DOI":"10.1016\/j.drudis.2023.103702","volume":"28","author":"FI Auwal","year":"2023","unstructured":"Auwal FI, Copeland C, Clark EJ, Naraynassamy C, McClelland GR. A systematic review of models of patient engagement in the development and life cycle management of medicines. Drug Discov Today. 2023;28(9):103702.","journal-title":"Drug Discov Today"},{"issue":"5","key":"926_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/2168479017706405","volume":"51","author":"J Geissler","year":"2017","unstructured":"Geissler J, Ryll B, di Priolo SL, Uhlenhopp M. Improving Patient Involvement in Medicines Research and Development:: A Practical Roadmap. Ther Innov Regul Sci. 2017;51(5):612\u20139.","journal-title":"Ther Innov Regul Sci"},{"key":"926_CR4","unstructured":"Patient Focused Medicines Development. The PFMD book of good practices 2nd edition patient focused medicines development. 2019 Available from: https:\/\/patientfocusedmedicine.org\/bogp\/2019\/the-book-of-good-practices.pdf."},{"key":"926_CR5","unstructured":"Association of the British Pharmaceutical Industry. Patient involvement. 2025. Available from: https:\/\/www.abpi.org.uk\/partnerships\/patient-involvement\/."},{"issue":"1","key":"926_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40900-023-00527-1","volume":"9","author":"B Dunstan","year":"2023","unstructured":"Dunstan B, Buchanan F, Maybee A, Lofters A, Sayani A. #HowNotToDoPatientEngagement: the engaging with purpose patient engagement framework based on a twitter analysis of community perspectives on patient engagement. Res Involv Engagem. 2023;9(1):119.","journal-title":"Res Involv Engagem"},{"issue":"1","key":"926_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40900-023-00418-5","volume":"9","author":"M Gonzalez","year":"2023","unstructured":"Gonzalez M, Ogourtsova T, Zerbo A, Lalonde C, Spurway A, Gavin F, et al. Patient engagement in a national research network: barriers, facilitators, and impacts. Res Involv Engagem. 2023;9(1):7.","journal-title":"Res Involv Engagem"},{"key":"926_CR8","unstructured":"Glenstall IT. Toolkits Mountain. 2023. Available from: https:\/\/pexlib.net\/?240843"},{"issue":"4","key":"926_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/01944366908977225","volume":"35","author":"SR Arnstein","year":"1969","unstructured":"Arnstein SR. A Ladder Of Citizen Participation. J Am Inst Planners. 1969;35(4):216\u201324.","journal-title":"J Am Inst Planners"},{"key":"926_CR10","unstructured":"peoplehub. Co-production - the spectrum of participation. 2023. Available from: https:\/\/www.peoplehub.org.uk\/co-production\/."},{"key":"926_CR11","doi-asserted-by":"publisher","unstructured":"Bharadia T. Patient Types. 2025. Available from: https:\/\/doi.org\/10.6084\/m9.figshare.29164754","DOI":"10.6084\/m9.figshare.29164754"},{"key":"926_CR12","doi-asserted-by":"crossref","unstructured":"Warner K, See W, Haerry D, Klingmann I, Hunter A, May M. EUPATI guidance for patient involvement in medicines research and development. Guidance for Pharmaceutical Industry-Led Medicines R&D. Front Med (Lausanne). 2018;5(R&D): 270.","DOI":"10.3389\/fmed.2018.00270"},{"issue":"2","key":"926_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/1467-9566.13588","volume":"45","author":"A Halloy","year":"2023","unstructured":"Halloy A, Simon E, Hejoaka F. Defining patient\u2019s experiential knowledge: Who, what and how patients know. A narrative critical review. Sociol Health Illn. 2023;45(2):405\u201322.","journal-title":"Sociol Health Illn"},{"issue":"8","key":"926_CR14","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1080\/03007995.2025.2545496","volume":"41","author":"A Rosenberg","year":"2025","unstructured":"Rosenberg A, Clark L, McClelland GR. Patient involvement in publications: qualitative mapping of the current landscape within the pharmaceutical industry. Curr Med Res Opin. 2025;41(8):1475\u201389.","journal-title":"Curr Med Res Opin"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40900-018-0104-4","volume":"4","author":"LB Mader","year":"2018","unstructured":"Mader LB, Harris T, Klager S, Wilkinson IB, Hiemstra TF. Inverting the patient involvement paradigm: defining patient led research. Res Involv Engagem. 2018;4:21.","journal-title":"Res Involv Engagem"},{"issue":"3","key":"926_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1177\/00336882231165061","volume":"55","author":"TACH Chan","year":"2024","unstructured":"Chan TACH, Ho JM-B, Tom M. Miro: Promoting Collaboration through Online Whiteboard Interaction. RELC J. 2024;55(3):871\u20135.","journal-title":"RELC J"},{"issue":"8","key":"926_CR17","doi-asserted-by":"publisher","first-page":"e071339","DOI":"10.1136\/bmjopen-2022-071339","volume":"13","author":"SA Dews","year":"2023","unstructured":"Dews SA, Bassi A, Buckland S, Clements L, Daley R, Davies A, et al. Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment. BMJ Open. 2023;13(8):e071339.","journal-title":"BMJ Open"},{"key":"926_CR18","doi-asserted-by":"crossref","unstructured":"Jones S, Flewett M, Flewett R, Lee S, Vick B, Thompson M, et al. Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations. ERJ Open Res. 2023;9(3).","DOI":"10.1183\/23120541.00602-2022"},{"key":"926_CR19","unstructured":"Taylor & Francis. Plain language summaries - advisory panel. 2025. Available from: https:\/\/www.plainlanguagesummaries.com\/advisory-panel\/."},{"issue":"8","key":"926_CR20","doi-asserted-by":"publisher","first-page":"e081222","DOI":"10.1136\/bmjopen-2023-081222","volume":"14","author":"SK Bagga","year":"2024","unstructured":"Bagga SK, Swiderska N, Hooker C, Royle J, Ennis-O\u2019Connor M, Freeney S, et al. Qualitative exploration of patients\u2019 experiences with Intrabeam TARGeted Intraoperative radioTherapy (TARGIT-IORT) and External-Beam RadioTherapy Treatment (EBRT) for breast cancer. BMJ Open. 2024;14(8):e081222.","journal-title":"BMJ Open"},{"issue":"3","key":"926_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.56012\/gyeg6536","volume":"33","author":"D Thavarajah","year":"2024","unstructured":"Thavarajah D, Baedorf Kassis S, Panton A, Bierer BE, Bharadia T. Creating educational materials about clinical research data for patients and the public: A multifaceted journey in the current digital age. Med Writ. 2024;33(3):46\u201353.","journal-title":"Med Writ"},{"key":"926_CR22","unstructured":"MRCT Center and PHUSE. Data literacy: MRCT center and PHUSE resources. 2025. Available from: https:\/\/mrctcenter.org\/resource\/data-infographics\/."},{"issue":"2","key":"926_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bmjinnov-2016-000157","volume":"3","author":"G Yeoman","year":"2017","unstructured":"Yeoman G, Furlong P, Seres M, Binder H, Chung H, Garzya V, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innov. 2017;3(2):76\u201383.","journal-title":"BMJ Innov"},{"key":"926_CR24","unstructured":"Merck KGaA. MS in the 21st Century. 2025. Available from: https:\/\/msinthe21stcentury.com\/en\/."},{"issue":"8","key":"926_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1080\/03007995.2025.2556317","volume":"41","author":"SR Stones","year":"2025","unstructured":"Stones SR, Lobban D, Skobe C, Gokool N, Bharadia T, Geraci A, et al. Patients as partners in medical publications: the ISMPP journey of engagement. Curr Med Res Opin. 2025;41(8):1491\u20138.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"926_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2923.2009.03530.x","volume":"44","author":"A Towle","year":"2010","unstructured":"Towle A, Bainbridge L, Godolphin W, Katz A, Kline C, Lown B, et al. Active patient involvement in the education of health professionals. Med Educ. 2010;44(1):64\u201374.","journal-title":"Med Educ"},{"issue":"2","key":"926_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.35680\/2372-0247.2039","volume":"12","author":"M Pomey","year":"2025","unstructured":"Pomey M, Wilhelmy C, Fournier-Tombs M, Dumez V, Vialaron C, Prevost K, et al. Partnership, Collaboration, and Co-Production to Improve Patient Experience Beyond Conducting Surveys \u2013 Lessons from the Quebec Model, Canada. Patient Experience J. 2025;12(2):112\u201323.","journal-title":"Patient Experience J"},{"key":"926_CR28","doi-asserted-by":"publisher","first-page":"100342","DOI":"10.1016\/j.ssmqr.2023.100342","volume":"4","author":"P Rowland","year":"2023","unstructured":"Rowland P, Forest P-G, Vanstone M, Leslie M, Abelson J. Exploring meanings of expert and expertise in patient engagement activities: A qualitative analysis of a pan-Canadian survey. SSM - Qualitative Res Health. 2023;4:100342.","journal-title":"SSM - Qualitative Res Health"},{"issue":"1","key":"926_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40900-022-00346-w","volume":"8","author":"J Oliver","year":"2022","unstructured":"Oliver J, Lobban D, Dormer L, Walker J, Stephens R, Woolley KL. Hidden in plain sight? Identifying patient-authored publications. Res Involv Engagem. 2022;8(1):12.","journal-title":"Res Involv Engagem"}],"container-title":["Research Involvement and Engagement"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-026-00926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40900-026-00926-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-026-00926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:28:21Z","timestamp":1781947701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40900-026-00926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1186\/s40900-026-00926-0","relation":{},"ISSN":["2056-7529"],"issn-type":[{"value":"2056-7529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No generative artificial intelligence was used in the development of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of generative artificial intelligence"}},{"value":"AR is an employee of Twist Medical LLC; this work is independent of her employment. She also receives consulting fees as a patient partner steering committee member of the Oxford Patient Engagement Network for Arthritis and Musculoskeletal Conditions (OPEN ARMS) at the University of Oxford, and as a PLS-P Reviewer for Sage Publishing. TB undertakes paid and unpaid consultancy and advocacy for various stakeholders in the life sciences and healthcare industries, including pharmaceutical companies, medical communications agencies, medical publishers, academia, and patient organizations. This work is independent of her consultancy. She is a visiting lecturer at the Centre for Pharmaceutical Medicine Research, King\u2019s College London. She serves on the editorial boards of The Research Post and Neurology and Therapy, is on the Patient Advisory Panel of Therapeutic Advances in Drug Safety, and is a member of the PLS Advisory Panel for Taylor & Francis, Sage Publishing and Becaris, for which she receives honoraria for plain language summary reviews. She is also a member of the ISMPP Patient Engagement Taskforce and the Good Publication Practice Steering Committee. GY is a Director of MediPaCe Ltd that provides patient involvement and research consultancy for the Life Science and Not for Profit sectors. LC owns shares in Merck & Co, Organon & Co, and provides paid consultancy to the pharmaceutical industry; this work is independent of her consultancy. GRM has no financial or other relationships to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}